• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Taral Patel, MD

Latest:

The Future of Oncology Research in a Shifting Policy Landscape

Panelists discuss how evolving policy reforms will reshape oncology research by balancing innovation, access, and affordability.


Dr Pankit Vachhani | Image Credit: UAB Medicine
Pankit Vachhani, MD

Latest:

Post Hoc Analysis Findings Offer Guidance for Anemia Management in Myelofibrosis: Pankit Vachhani, MD

A post hoc analysis of the phase 3b JUMP trial supports the real-world use of ruxolitinib with anemia supportive care to maintain dosing and clinical outcomes in patients with myelofibrosis, offering a practical strategy that does not compromise efficacy.



Dan Nardi, MS | Image Credit: Reimagine Care
Dan Nardi, MS

Latest:

Experts Push to Preserve Telehealth, Payment Parity Post Pandemic

Experts agree that the expansion of telehealth was one of the most significant positive outcomes of the COVID-19 pandemic.



Joshua J. Gagne, PharmD, ScD

Latest:

Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists

Changes in generic drug appearance occur often. Patients’ and pharmacists’ responses to those changes vary, with some patients stopping their medication or using it less.


Mohammed Yousufuddin, MD, MSc

Latest:

Discharge Timing and Associations With Outcomes Following Heart Failure Hospitalization

A retrospective multicenter study found that patients with heart failure discharged by noon had higher short- and long-term mortality and increased early readmission rates compared with afternoon discharges.


Blake Ayers, MPH

Latest:

Mental Health Care Use After Leaving Medicare Advantage for Traditional Medicare

Medicare Advantage beneficiaries with mental health diagnoses see more nurse practitioners and fewer internal medicine and emergency medicine specialists after switching to traditional Medicare.


Djibril Liassou, MS

Latest:

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.


Venus Wong, PhD

Latest:

Achieving Better Value in Pediatric Care: School Systems as Clinical and Financial Partners?

This article argues that value-based health systems may contract with school districts engaged in capitated special education to achieve better patient outcomes and lower costs for the pediatric population.


Daniel P. Kessler, PhD

Latest:

The Relationship Between Provider Age and Opioid Prescribing Behavior

Holding other factors constant, the authors find that older providers prescribe significantly more opioids, with the gap between older and younger providers increasing from 2010 to 2015.


Andrea Jacobson, MPH

Latest:

Building Research Capacity in Primary Care Practices That Serve Predominantly Racial and Ethnic Minority Populations

The successful collaboration between a primary care–based network of practices and academic researchers demonstrates feasibility and the need for more funding for primary care research.


Chinonso Ani, BS

Latest:

Operating Room Efficiency of Orthopedic Surgery During the COVID-19 Era

The authors analyzed the impacts of COVID-19 on orthopedic operating room efficiency via comparison of 14,856 surgeries performed before, during, and after the pandemic.


Kurt B. Angstman, MD

Latest:

Emergency Department Risk Model: Timely Identification of Patients for Outpatient Care Coordination

The authors created a machine learning–based model to identify patients with major depressive disorder in the primary care setting at high risk of frequent emergency department visits, enabling prioritization for a care coordination program.


Dana Howard, PhD

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Phyo K. Myint, MD

Latest:

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.


Richard Schwartz, BS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Kimberly J. Erlich, MSN, MPH, RN, CPNP, PMHS

Latest:

Primary Care Nurse Practitioner Management of Adolescent Behavioral Health

Personnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).


Kenneth C. Hohmeier, PharmD

Latest:

Amazon Pharmacy: Distraction or Disruption?

After years of anticipation, Amazon Pharmacy launched in November 2020. The question is now: Is this market entry a disruption, a distraction, or something in between?


Cathy Eng, MD, FACP, FASCO | Image Credit: © Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO

Latest:

We Do Our Best to Serve the Community: Cathy Eng, MD, FACP, FASCO

Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center, speaks about the clinical and operational priorities that academic medical centers make front-and-center when caring for underserved populations receiving treatment for cancer.


David M. Miller, MBA

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Jordan Rosedahl, BS

Latest:

Impact of Advance Care Planning Consults on Advance Directives Completion

Implementing advance care planning consults can increase advance directive completion rates. The authors demonstrate the impact of consults on completed advance directives in the medical record.


Aisha T. Langford, PhD, MPH

Latest:

When Does Nonadherence Indicate a Deviation From Patient-Centered Care?

The authors suggest that assessment of patient-centered care may be improved by flagging probable discordance between a patient’s preferences and their treatment care plan.


Katherine Koh, MD, MSc

Latest:

Multisector Approach Best for Reducing Homeless Individuals in the Streets: Katherine Koh, MD, MSc

Approaching homelessness through prevention and local government policies is the next step in addressing increased incidence of homelessness, said Katherine Koh, MD, MSc.


Roy G. Marcus, MD

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Millie Mo, PharmD

Latest:

Navigating Compounded Semaglutide: What Health Care Providers Need to Know

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.



Caleb J. Scheckel, DO

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.


Brianna Rhue, OD, FAAO

Latest:

Experts Recount What Aspects of SECO Will Be Vital to Their Future Practice

Attendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.


Jason Harris

Latest:

FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple Myeloma

The FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.